Toxicology

A topic in the Science corpus, drawn from 280 papers.

Trusted voices in Toxicology

Ordered by the trust Toxicology's own network concentrates on each researcher, most first.

  1. David S. Wishart — trusted by 13 researchers here
  2. Paul Stothard — trusted by 12 researchers here
  3. R. Jesse — trusted by 7 researchers here
  4. U. McCann — trusted by 7 researchers here
  5. James J. Champoux — trusted by 4 researchers here
  6. Abeed Sarker — trusted by 7 researchers here
  7. M. Maiorino — trusted by 6 researchers here
  8. Russ B. Altman — trusted by 5 researchers here
  9. Patrick Ye — trusted by 5 researchers here
  10. Roxana Daneshjou — trusted by 5 researchers here
  11. Nicholas P. Tatonetti — trusted by 5 researchers here
  12. Yves Pommier — trusted by 3 researchers here

Most-cited papers in Toxicology

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients (2004, British medical journal) — 3,313 citations
  2. Crosstalk of reactive oxygen species and NF-κB signaling (2011, Cell Research) — 3,168 citations
  3. Adverse drug reactions: definitions, diagnosis, and management. (2000, The Lancet) — 2,833 citations
  4. DNA topoisomerases: structure, function, and mechanism. (2001, Annual Review of Biochemistry) — 2,641 citations
  5. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada (2004, Canadian Medical Association Journal) — 2,435 citations
  6. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2016, Arthritis care & research) — 2,430 citations
  7. The Danish National Prescription Registry (2011, Scandinavian Journal of Public Health) — 2,377 citations
  8. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008, Chest) — 2,275 citations
  9. Adverse events in British hospitals: preliminary retrospective record review (2001, British medical journal) — 2,058 citations
  10. Glutathione peroxidases. (2013, Biochimica et Biophysica Acta) — 1,946 citations
  11. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (2002, Cell) — 1,893 citations
  12. Estrogen receptors: how do they signal and what are their targets. (2007, Physiological Reviews) — 1,835 citations
  13. Guide to Receptors and Channels (GRAC), 3rd edition (2008) — 1,780 citations
  14. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. (2003, Journal of the American Medical Association (JAMA)) — 1,780 citations
  15. Emergency hospitalizations for adverse drug events in older Americans. (2011, New England Journal of Medicine) — 1,720 citations
  16. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (2001, Pharmacoepidemiology and Drug Safety) — 1,699 citations
  17. The reinstatement model of drug relapse: history, methodology and major findings (2003, Psychopharmacology) — 1,660 citations
  18. Organoselenium and organotellurium compounds: toxicology and pharmacology. (2004, Chemical Reviews) — 1,659 citations
  19. Role of quinones in toxicology. (2000, Chemical Research in Toxicology) — 1,603 citations
  20. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. (2005, The Lancet) — 1,527 citations
  21. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. (2008, International journal of clinical pharmacology and therapeutics) — 1,503 citations
  22. Under-Reporting of Adverse Drug Reactions (2006, Drug Safety) — 1,501 citations
  23. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA (2003, Nature) — 1,438 citations
  24. Pharmacological and toxicological properties of Nigella sativa (2003, Phytotherapy Research) — 1,398 citations
  25. Chemistry of biologically important synthetic organoselenium compounds. (2001, Chemical Reviews) — 1,386 citations
  26. Apoptosis: A Target for Anticancer Therapy (2018, International Journal of Molecular Sciences) — 1,361 citations
  27. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies (2000, Psychopharmacology) — 1,359 citations
  28. A review on therapeutic potential of Nigella sativa: A miracle herb. (2013, Asian Pacific Journal of Tropical Biomedicine) — 1,329 citations
  29. A review of uses of health care utilization databases for epidemiologic research on therapeutics. (2005, Journal of Clinical Epidemiology) — 1,320 citations
  30. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment… (2005, Biological Psychiatry) — 1,312 citations
  31. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. (2006, Journal of the American Medical Association (JAMA)) — 1,278 citations
  32. Polypharmacy in elderly patients. (2007, The American Journal of Geriatric Pharmacotherapy) — 1,262 citations
  33. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions (2002, Pharmacoepidemiology and Drug Safety) — 1,252 citations
  34. T Cell Activation (2009, Annual Review of Immunology) — 1,246 citations
  35. Adverse drug events in ambulatory care. (2003, New England Journal of Medicine) — 1,244 citations
  36. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (2016, Lancet psychiatry) — 1,242 citations
  37. Mechanisms and functions of eph and ephrin signalling (2002, Nature reviews. Molecular cell biology) — 1,242 citations
  38. The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003, Pharmacological Reviews) — 1,231 citations
  39. Impact of natural products on developing new anti-cancer agents. (2009, Chemical Reviews) — 1,226 citations
  40. Van der Waals Radii of Elements (2001) — 1,221 citations
  41. Base-excision repair of oxidative DNA damage (2007, Nature) — 1,212 citations
  42. Development of a rational scale to assess the harm of drugs of potential misuse. (2007, The Lancet) — 1,206 citations
  43. Systematic overview of warfarin and its drug and food interactions. (2005, Archives of Internal Medicine) — 1,182 citations
  44. A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol (2007, Chemistry and Biology) — 1,144 citations
  45. Mechanism of Quinolone Action and Resistance (2014, Biochemistry) — 1,143 citations
  46. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. (2013, Journal of Medicinal Chemistry) — 1,112 citations
  47. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data (2009) — 1,091 citations
  48. Methods for evaluation of medication adherence and persistence using automated databases (2006, Pharmacoepidemiology and Drug Safety) — 1,087 citations
  49. Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine (2000, Journal of Neuroscience) — 1,077 citations
  50. Human Cannabinoid Pharmacokinetics (2007, Chemistry and Biodiversity) — 1,060 citations

Most active researchers

By papers in this topic: a volume measure, not trust.